Search research articles
Contact Us
Filters
Showing results (171-180 of 203) with videos related to
Page
of 21
Sort By:
Blood
|
July 27, 2000
Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure
M L Liu, B W Shen, S Nakaya, et al.
Surgical Endoscopy
|
September 1, 1994
The integration of laparoscopy into a surgical residency and implications for the training environment
C E Scott-Conner, T J Hall, B L Anglin, et al.
Wilderness & Environmental Medicine
|
December 23, 2008
Manual assessment of the initial fall in blood pressure after orthostatic challenge at high altitude
Oliver T Mytton, Alistair Simpson, Alfred A R Thompson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 11, 2006
Ethical issues in haemophilia
D DiMichele, A Chuansumrit, A J London, et al.
The European Respiratory Journal
|
September 24, 2016
Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension
Peter M Hickey, Alfred A R Thompson, Athanasios Charalampopoulos, et al.
Endocrinology
|
May 11, 1992
Somatic gene transfer in the development of an animal model for primary hyperparathyroidism
J M Wilson, M Grossman, A R Thompson, et al.
Blood
|
August 15, 1989
Mapping of monoclonal antibodies to human factor IX
D Frazier, K J Smith, W F Cheung, et al.
American Journal of Hematology
|
July 1, 1992
Coagulation factor IX: successful surgical experience with a purified factor IX concentrate
J C Goldsmith, C K Kasper, P M Blatt, et al.
Journal of Medicinal Chemistry
|
August 1, 1984
Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity
C D Jones, M G Jevnikar, A J Pike, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs
M A Kay, C N Landen, S R Rothenberg, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 203) with videos related to
Sort By:
Page
of 21
Blood
|
July 27, 2000
Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure
M L Liu, B W Shen, S Nakaya, et al.
Surgical Endoscopy
|
September 1, 1994
The integration of laparoscopy into a surgical residency and implications for the training environment
C E Scott-Conner, T J Hall, B L Anglin, et al.
Wilderness & Environmental Medicine
|
December 23, 2008
Manual assessment of the initial fall in blood pressure after orthostatic challenge at high altitude
Oliver T Mytton, Alistair Simpson, Alfred A R Thompson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 11, 2006
Ethical issues in haemophilia
D DiMichele, A Chuansumrit, A J London, et al.
The European Respiratory Journal
|
September 24, 2016
Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension
Peter M Hickey, Alfred A R Thompson, Athanasios Charalampopoulos, et al.
Endocrinology
|
May 11, 1992
Somatic gene transfer in the development of an animal model for primary hyperparathyroidism
J M Wilson, M Grossman, A R Thompson, et al.
Blood
|
August 15, 1989
Mapping of monoclonal antibodies to human factor IX
D Frazier, K J Smith, W F Cheung, et al.
American Journal of Hematology
|
July 1, 1992
Coagulation factor IX: successful surgical experience with a purified factor IX concentrate
J C Goldsmith, C K Kasper, P M Blatt, et al.
Journal of Medicinal Chemistry
|
August 1, 1984
Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity
C D Jones, M G Jevnikar, A J Pike, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs
M A Kay, C N Landen, S R Rothenberg, et al.
Page
of 21